United States

Third party FCPA compliance for life sciences companies

VIDEO

As your life sciences company leverages resources abroad and expands globally, compliance with the Foreign Corrupt Practices Act (FCPA) becomes a business imperative for your organization. Noncompliance with these strict laws, whether through your immediate business or via your third-party relationships, could be costly from a reputational standpoint as well as affect your bottom line and future profitability. How do you get to the core of what’s needed from your business to mitigate these regulatory risks?

Watch this video to learn more about some of the strategies that can uncover FCPA noncompliance with new or existing third parties, like leveraging a scoring matrix, focused vetting efforts as well as specialized due diligence. For additional information on this topic, check out the infographic below.

INFOGRAPHIC

Click to enlarge the infographic and learn more.

Third party FCPA compliance for life sciences companies

 

 


YOU MAY ALSO BE INTERESTED IN

INSIGHT ARTICLE

Life sciences companies: Is your third party FCPA-compliant?

Learn considerations for life sciences companies when it comes to FCPA compliance and third party risk management.

INSIGHT ARTICLE

Contract compliance audits uncover life sciences company lost profits

RSM’s life sciences industry insider shares key insights and benefits of conducting a third-party contract compliance audit.

INSIGHT ARTICLE

Third parties, 3 risks and your life sciences business

Third parties provide a vital business partnership for growing life sciences companies, but there are risks to consider.

Want more information?

Download the ebook, Managing third-party risks across your life sciences business, to learn more.

READ THE E-BOOK


Life Sciences Insights

( * = Required fields)